1. The Defendant’s KRW 242,518,55 for the Plaintiff and KRW 6% per annum from August 27, 2016 to June 15, 2018.

Basic Facts

A. The Plaintiff is a company that runs the wholesale and retail business of pharmaceutical products and medical appliances, and the Defendant is a person who runs the wholesale and retail business of pharmaceutical products under the trade name of “C”.

B. From July 1, 2016 to August 26, 2016, the Plaintiff supplied the Defendant with drugs equivalent to KRW 264,518,555 in total, including 500 mgluta-si, 500 margs.

(hereinafter “instant drug”). C.

D Co., Ltd. (hereinafter “D”) is a company that runs the drug wholesale business, etc., and the Defendant served as D’s representative director from March 31, 2010 to May 7, 2014, and is serving as D’s auditor from May 7, 2014, and E, an employee of C, is serving as D’s representative director from May 7, 2014.

According to the facts acknowledged prior to the determination of the grounds for a claim as a whole, the Defendant is obligated to pay to the Plaintiff the drug price of this case, KRW 264,518,55, and delay damages therefrom, except in extenuating circumstances.

From July 6, 2016 to September 8, 2016, the Defendant asserted that the instant medicine was fully repaid, since the Defendant remitted the sum of KRW 26,99,265 in excess of the instant medicine price to the new bank account (Account Number G; hereinafter “new bank account”) in the name of the Plaintiff’s representative director and the Daegu Bank account (Account Number H; hereinafter “TF account”) in the name of the Plaintiff to the Daegu Bank account in the name of the Plaintiff.

In full view of the purport of the entire arguments in each statement of No. 1-1 and No. 10 of the evidence No. 1-10, the Plaintiff may recognize the fact that the Defendant remitted to the new bank account KRW 10,000,000 on July 6, 2016, and KRW 10,000,000 on August 9, 2016. (B) In addition to the instant medicine, the Plaintiff provided the Defendant with the medicine in addition to the instant medicine, and the sum of KRW 22,00,000 transferred to the new bank account is paid for that.